A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers

Condition:   Healthy VolunteersInterventions:   Drug: ketoconazole-placebo;   Drug: placebo-ketoconazoleSponsor:   Eisai Inc.Completed - verified January 2015

Source: ClinicalTrials.gov - July 21, 2014 Category: Research Source Type: clinical trials